Efficacy and Safety of Visepegenatide As an Add-on Therapy to Metformin in Patients with Type 2 Diabetes: a Randomised, Double-Blind, Parallel, Placebo-Controlled, Phase 3 Study

Xiaoling Cai,Linong Ji,Mingxia Yuan,Jianhua Ma,Fang Bian,Sheli Li,Wuyan Pang, Shuang Yan,Huimin Zhou, Minghui Hou,Wenhui Li, Ying Jia, Li Liu, Ke Ding,Michael Xu

The Lancet Regional Health - Western Pacific（2024）

引用 0|浏览5
暂无评分
关键词
Add-on therapy,Visepegenatide,Metformin,GLP-1 receptor agonist,Type 2 diabetes mellitus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要